M&A
confidence high
sentiment positive
materiality 0.75
Aesther enters $60M backstop agreement with Vellar to support Ocean Biomedical merger
Ocean Biomedical, Inc.
- Vellar to purchase up to 6M AEHA shares in open market for up to $60M to backstop merger redemptions.
- Aesther will buy those shares on forward basis; prepayment equals redemption price per share.
- Backstop matures 3 years after closing or earlier if VWAP drops below $4 for 30 of 45 consecutive trading days.
- Vellar receives $12.408M from trust account for share consideration shares not subject to backstop.
- Break-up fee of $1M plus expenses payable to Vellar if business combination fails under certain conditions.